Manufacturing of products made at the Barceloneta, Puerto Rico plant will be moved to other sites.

Unilife to begin commercial supply in 2014.

Annual growth in spending for medicines is expected to rise from 2-3% in 2013 to 5-7% in 2017, the highest pace of growth since 2009.

GlaxoSmithKline will build a new solid dosage manufacturing facility in India.

Catalent has signed a product development agreement with immunology company Pure MHC (major histocompatibility complex), which specializes in MHC-based diagnostics and therapeutics.

Plan outlines key areas of collaboration.

An operational-excellence initiative increased collaboration between operations and quality personnel to address human-error-caused deviations.

New CDMO to be formed from the combination of DSM Pharmaceutical Products and Patheon in a $2.6-billion transaction.

Xcelience appoints Clinical Supplies VP of its new Birmingham, United Kingdom site.

Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing (NGS) based biosafety assessments to detect and identify viral contaminants within biologic compounds.

Ei Lilly announces investments in insulin manufacturing capacity for its sites in Indianapolis, Puerto Rico, France, and China.

Intertek is now offering comprehensive services for the development of orally inhaled and intranasal drug products (OINDPs) for both small molecules and biologics.

The systems are designed for the manufacture of oncology products and to research new biotech products.

Association recognizes groundbreaking researchers in the field of pharmaceutical sciences.

Shire-s agreement to acquire ViroPharma will strengthen its rare-disease portfolio.

AstraZeneca will build a new facility in the United Kingdom to produce Zoladex, an injectable prostrate cancer treatment.

Grifols expands and diversifies portfolio with acquisition of diagnostic business.

Lyra Myers, associate director and value creation agent at Roche, has been elected DCAT president.

Former President Jimmy Carter and Pfizer mark milestone for long-standing partnership to combat trachoma in the developing world.

Generic Drug Super Office Takes Shape

New interactive web tool helps innovators match formulations to drug delivery technologies.

Breakthrough Therapies Raise Manufacturing Issues

FDA Promotes Personalized Medicine

The restructuring will put more than 100 R&D jobs at risk as the company scales back on drug development with the aim of simplifying its business to focus on rare disease.

FDA Moves to Curb Drug Shortages

Biotechnology Industry Organization President James Greenwood writes senators in support of Start-up Jobs and Innovation Act.

Includes a new approach on developing antibacterial agents targeted against multidrug-resistant (MDR) pathogens where patients have very limited or no remaining treatment options.

ISPE names Novartis' US Flu Cell Culture facility as award winner.